BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 27568661)

  • 1. Increased Plasma Levels of Pentraxin 3 Are Associated with Poor Prognosis of Colorectal Carcinoma Patients.
    Zhang J; Wang TY; Niu XC
    Tohoku J Exp Med; 2016 Sep; 240(1):39-46. PubMed ID: 27568661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased serum pentraxin-3 level predicts poor prognosis in patients with colorectal cancer after curative surgery, a cohort study.
    Liu B; Zhao Y; Guo L
    Medicine (Baltimore); 2018 Oct; 97(40):e11780. PubMed ID: 30290589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma Pentraxin 3 Is Closely Associated with Peripheral Arterial Disease in Hemodialysis Patients and Predicts Clinical Outcome: A 6-Year Follow-Up.
    Zhou Y; Zhang J; Zhu M; Lu R; Wang Y; Ni Z
    Blood Purif; 2015; 39(4):266-73. PubMed ID: 25924996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pentraxin-3 level at admission is a strong predictor of short-term mortality in a community-based hospital setting.
    Bastrup-Birk S; Munthe-Fog L; Skjoedt MO; Ma YJ; Nielsen H; Køber L; Nielsen OW; Iversen K; Garred P
    J Intern Med; 2015 May; 277(5):562-72. PubMed ID: 25143177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pentraxin 3 as a biomarker of local inflammatory response to vascular injury in systemic lupus erythematosus.
    Cieślik P; Hrycek A
    Autoimmunity; 2015 Jun; 48(4):242-50. PubMed ID: 25401491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pentraxin 3 (PTX3) is associated with severe sepsis and fatal disease in emergency room patients with suspected infection: a prospective cohort study.
    Uusitalo-Seppälä R; Huttunen R; Aittoniemi J; Koskinen P; Leino A; Vahlberg T; Rintala EM
    PLoS One; 2013; 8(1):e53661. PubMed ID: 23341967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significant elevation of plasma pentraxin 3 in patients with pelvic inflammatory disease.
    Chang CC; Wang PH; Su PH; Lin DB; Ying TH; Yang SF; Hsieh YH
    Clin Chem Lab Med; 2011 Oct; 49(10):1655-60. PubMed ID: 21679133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical value of plasma pentraxin 3 levels for predicting cardiac troponin elevation after percutaneous coronary intervention.
    Wang Z; Sato A; Akiyama D; Kimura T; Tajiri K; Hoshi T; Sakai S; Koike A; Miyauchi T; Aonuma K
    Life Sci; 2014 Jan; 95(1):40-4. PubMed ID: 24333560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pentraxin 3, long expression in mononuclear cells of patients with acute coronary syndrome: Correlation with C-reactive protein and matrix metalloproteinase-9 levels.
    Ma R; Zhang W; Wang T; He X; Huang Z; Zhu J; Yao Z
    J Int Med Res; 2014 Jun; 42(3):677-83. PubMed ID: 24709882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High plasma level of long pentraxin 3 (PTX3) is associated with fatal disease in bacteremic patients: a prospective cohort study.
    Huttunen R; Hurme M; Aittoniemi J; Huhtala H; Vuento R; Laine J; Jylhävä J; Syrjänen J
    PLoS One; 2011 Mar; 6(3):e17653. PubMed ID: 21423699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of plasma pentraxin-3 levels in patients with stable coronary artery disease after drug-eluting stent implantation.
    Haibo L; Xiaofang G; Chunming W; Jie Y; Guozhong C; Limei Z; Yong C; Yu F; Yingchun B; Wangjun Y; Junbo G
    Mediators Inflamm; 2014; 2014():963096. PubMed ID: 25538378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic and diagnostic potential of local and circulating levels of pentraxin 3 in lung cancer patients.
    Infante M; Allavena P; Garlanda C; Nebuloni M; Morenghi E; Rahal D; Roncalli M; Cavuto S; Pesce S; Monari M; Valaperta S; Montanelli A; Solomon D; Bottoni E; Errico V; Voulaz E; Bossi M; Chiesa G; Passera E; Mantovani A; Alloisio M
    Int J Cancer; 2016 Feb; 138(4):983-91. PubMed ID: 26348770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pentraxin levels in non-eosinophilic versus eosinophilic asthma.
    Gao P; Tang K; Wang M; Yang Q; Xu Y; Wang J; Zhao J; Xie J
    Clin Exp Allergy; 2018 Aug; 48(8):981-989. PubMed ID: 29754456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pentraxin 3, a new marker for vascular inflammation, predicts adverse clinical outcomes in patients with heart failure.
    Suzuki S; Takeishi Y; Niizeki T; Koyama Y; Kitahara T; Sasaki T; Sagara M; Kubota I
    Am Heart J; 2008 Jan; 155(1):75-81. PubMed ID: 18082493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated levels of the long pentraxin 3 in paracetamol-induced human acute liver injury.
    Craig DG; Lee P; Pryde EA; Walker SW; Beckett GJ; Hayes PC; Simpson KJ
    Eur J Gastroenterol Hepatol; 2013 Mar; 25(3):359-67. PubMed ID: 23169308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incremental prognostic significance of the elevated levels of pentraxin 3 in patients with heart failure with normal left ventricular ejection fraction.
    Matsubara J; Sugiyama S; Nozaki T; Akiyama E; Matsuzawa Y; Kurokawa H; Maeda H; Fujisue K; Sugamura K; Yamamoto E; Matsui K; Jinnouchi H; Ogawa H
    J Am Heart Assoc; 2014 Jul; 3(4):. PubMed ID: 25012287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated plasma level of pentraxin-3 predicts in-hospital and 30-day clinical outcomes in patients with non-ST-segment elevation myocardial infarction who have undergone percutaneous coronary intervention.
    Guo R; Li Y; Wen J; Li W; Xu Y
    Cardiology; 2014; 129(3):178-88. PubMed ID: 25323314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pentraxin-3 serum levels are associated with disease severity and mortality in patients with systemic inflammatory response syndrome.
    Bastrup-Birk S; Skjoedt MO; Munthe-Fog L; Strom JJ; Ma YJ; Garred P
    PLoS One; 2013; 8(9):e73119. PubMed ID: 24039869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and prognostic implications of circulating pentraxin 3 levels in non ST-elevation acute coronary syndrome.
    Eggers KM; Armstrong PW; Califf RM; Johnston N; Simoons ML; Venge P; James SK
    Clin Biochem; 2013 Nov; 46(16-17):1655-9. PubMed ID: 24012697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pentraxin-3 in chronic heart failure: the CORONA and GISSI-HF trials.
    Latini R; Gullestad L; Masson S; Nymo SH; Ueland T; Cuccovillo I; Vårdal M; Bottazzi B; Mantovani A; Lucci D; Masuda N; Sudo Y; Wikstrand J; Tognoni G; Aukrust P; Tavazzi L;
    Eur J Heart Fail; 2012 Sep; 14(9):992-9. PubMed ID: 22740508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.